Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83. doi: 10.1073/pnas.94.17.9378.

Abstract

It is generally thought that an effective vaccine to prevent HIV-1 infection should elicit both strong neutralizing antibody and cytotoxic T lymphocyte responses. We recently demonstrated that potent, boostable, long-lived HIV-1 envelope (Env)-specific cytotoxic T lymphocyte responses can be elicited in rhesus monkeys using plasmid-encoded HIV-1 env DNA as the immunogen. In the present study, we show that the addition of HIV-1 Env protein to this regimen as a boosting immunogen generates a high titer neutralizing antibody response in this nonhuman primate species. Moreover, we demonstrate in a pilot study that immunization with HIV-1 env DNA (multiple doses) followed by a final immunization with HIV-1 env DNA plus HIV-1 Env protein (env gene from HXBc2 clone of HIV IIIB; Env protein from parental HIV IIIB) completely protects monkeys from infection after i.v. challenge with a chimeric virus expressing HIV-1 env (HXBc2) on a simian immmunodeficiency virusmac backbone (SHIV-HXBc2). The potent immunity and protection seen in these pilot experiments suggest that a DNA prime/DNA plus protein boost regimen warrants active investigation as a vaccine strategy to prevent HIV-1 infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines*
  • Animals
  • Cytotoxicity, Immunologic
  • DNA, Viral / administration & dosage*
  • DNA, Viral / immunology
  • Gene Products, env / immunology*
  • Genes, env*
  • HIV Infections / immunology
  • HIV Infections / prevention & control*
  • HIV-1 / immunology*
  • Haplorhini
  • Humans
  • Immunization
  • Reassortant Viruses / immunology
  • T-Lymphocytes / immunology

Substances

  • AIDS Vaccines
  • DNA, Viral
  • Gene Products, env